Folgen
Yiran Zheng
Titel
Zitiert von
Zitiert von
Jahr
Structure-based programming of lymph-node targeting in molecular vaccines
H Liu, KD Moynihan, Y Zheng, GL Szeto, AV Li, B Huang, DS Van Egeren, ...
Nature 507 (7493), 519-522, 2014
8742014
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
L Tang, Y Zheng, MB Melo, L Mabardi, AP Castaño, YQ Xie, N Li, ...
Nature biotechnology 36 (8), 707-716, 2018
5082018
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
D Schmid, CG Park, CA Hartl, N Subedi, AN Cartwright, RB Puerto, ...
Nature communications 8 (1), 1747, 2017
3902017
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
B Huang, WD Abraham, Y Zheng, SC Bustamante López, SS Luo, ...
Science translational medicine 7 (291), 291ra94-291ra94, 2015
3152015
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Y Zheng, MT Stephan, SA Gai, W Abraham, A Shearer, DJ Irvine
Journal of controlled release 172 (2), 426-435, 2013
1442013
Enhancing adoptive cell therapy of cancer through targeted delivery of small-molecule immunomodulators to internalizing or noninternalizing receptors
Y Zheng, L Tang, L Mabardi, S Kumari, DJ Irvine
ACS nano 11 (3), 3089-3100, 2017
1332017
Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells
YQ Xie, H Arik, L Wei, Y Zheng, H Suh, DJ Irvine, L Tang
Biomaterials science 7 (4), 1345-1357, 2019
682019
ZIF nano-dagger coated gauze for antibiotic-free wound dressing
Y Yuan, H Wu, H Lu, Y Zheng, JY Ying, Y Zhang
Chemical communications 55 (5), 699-702, 2019
622019
Polymers with distinctive anticancer mechanism that kills MDR cancer cells and inhibits tumor metastasis
G Zhong, C Yang, S Liu, Y Zheng, W Lou, JY Teo, C Bao, W Cheng, ...
Biomaterials 199, 76-87, 2019
552019
Immuno‐Engineered Nanodecoys for the Multi‐Target Anti‐Inflammatory Treatment of Autoimmune Diseases
M Hou, Y Wei, Z Zhao, W Han, R Zhou, Y Zhou, Y Zheng, L Yin
Advanced Materials 34 (12), 2108817, 2022
532022
Immune checkpoint inhibitor‐based strategies for synergistic cancer therapy
M He, T Yang, Y Wang, M Wang, X Chen, D Ding, Y Zheng, H Chen
Advanced Healthcare Materials 10 (9), 2002104, 2021
522021
Dual-sensitive micellar nanoparticles regulate DNA unpacking and enhance gene-delivery efficiency
X Jiang, Y Zheng, HH Chen, KW Leong, TH Wang, HQ Mao
Advanced materials (Deerfield Beach, Fla.) 22 (23), 2556, 2010
522010
In vivo targeting of cells with ligand-conjugated particles
DJ Irvine, Y Zheng
US Patent App. 14/309,513, 2014
392014
Platelet Pharmacytes for the Hierarchical Amplification of Antitumor Immunity in Response to Self‐Generated Immune Signals
J Yan, X Liu, F Wu, C Ge, H Ye, X Chen, Y Wei, R Zhou, S Duan, R Zhu, ...
Advanced Materials 34 (23), 2109517, 2022
322022
Process automation toward ultra-high-throughput screening of combinatorial one-bead-one-compound (OBOC) peptide libraries
J Cha, J Lim, Y Zheng, S Tan, YL Ang, J Oon, MW Ang, J Ling, M Bode, ...
Journal of laboratory automation 17 (3), 186-200, 2012
272012
Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
Y Huang, X Wang, Y Zheng, W Chen, Y Zheng, G Li, W Lou, X Wang
Aging (Albany NY) 13 (1), 1153, 2021
252021
pH-Degradable imidazolium oligomers as antimicrobial materials with tuneable loss of activity
Y Yuan, DSW Lim, H Wu, H Lu, Y Zheng, ACA Wan, JY Ying, Y Zhang
Biomaterials science 7 (6), 2317-2325, 2019
222019
Calcium cross-linked zwitterionic hydrogels as antifouling materials
HM Chan, N Erathodiyil, H Wu, H Lu, Y Zheng, JY Ying
Materials Today Communications 23, 100950, 2020
162020
Cell surface coupling of nanoparticles
DJ Irvine, Y Zheng, L Tang
US Patent 11,034,752, 2021
152021
In vivo targeting of cells with ligand-conjugated particles
DJ Irvine, Y Zheng, Y Zhang, B Kwong
US Patent App. 15/195,571, 2016
112016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20